Bio-Techne Corporation
S&P 500Last update: May 9, 2026 at 09:32
Dividend Safety Rating
TECH's dividend appears very safe. Strengths include a 45.7% earnings payout ratio & 22.4% fcf payout ratio. Areas of concern: 5.3% return on equity & Volatile profit margin stability.
Based on 15 of 15 metrics
Strengths
- Earnings Payout Ratio: 45.7%Low earnings payout ratio leaves room to grow the dividend.
- FCF Payout Ratio: 22.4%Free cash flow comfortably covers the dividend.
- CFO Payout Ratio: 27.1%Operating cash flow strongly supports the payout.
Risks
- Return on Equity: 5.3%Return on equity is below industry norms.
- Profit Margin Stability: VolatileProfit margins have been volatile.
- 5-Year Dividend CAGR: 0.0%Dividend growth has been weak or negative.
Payout & Coverage
Very SafeBalance Sheet
Very SafeProfitability
CautionDividend Track Record
SafeAbout Bio-Techne Corporation
Bio-Techne Corporation is a global developer, manufacturer and supplier of high-quality reagents, analytical instruments, and precision diagnostics serving the research, diagnostic, and bioprocessing markets worldwide. The company operates through two primary segments: protein sciences, which develops biological reagents including cytokines, growth factors, antibodies, and cell selection technologies; and diagnostics and spatial biology, which provides diagnostic reagents, molecular diagnostics, and spatial biology products. Bio-Techne maintains an extensive catalog of over 500,000 products, with approximately 95% manufactured in-house. Its portfolio includes flagship brands such as R&D Systems, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Asuragen, and Tocris Bioscience, serving academic research institutions, pharmaceutical and biotechnology companies, clinical diagnostic laboratories, and government agencies. Headquartered in Minneapolis, Minnesota, the company operates manufacturing facilities, research centers, and customer support offices across North America, Europe, and Asia-Pacific, generating significant revenue from the United States while maintaining a strong international presence. Bio-Techne's reputation for high-quality proteomic reagents and instruments enables it to maintain strong margins and cash flow while supporting scientific discovery and clinical breakthroughs.
Dividend Overview
Dividend Yield
0.66%
Annual Dividend
$0.32
Frequency
Quarterly
Payout Ratio
45.71%
FCF Payout Ratio
22.37%
Stock Price
$48.36
52-Week Range
$45.12 – $72.16
Dividend History (2016–2025)
TECH annual dividend per share and yield history
Earnings & Profitability
TECH earnings per share and net profit margin
Key Dates
Next Ex-Dividend Date
May 18, 2026
Last Payment Date
February 27, 2026
Dividend Growth
3-Year Dividend CAGR
0.00%
5-Year Dividend CAGR
0.00%
10-Year Dividend CAGR
0.00%
3-Year Total Growth
0.00%
5-Year Total Growth
0.00%
10-Year Total Growth
0.00%
Income Calculator
Similar Dividend Stocks
| Stock | Yield | 5Y CAGR | Price |
|---|---|---|---|
| 0.66% | 0.00% | $48.36 | |
| 0.00% | N/A | $54.35 |
Frequently Asked Questions
What is TECH's current dividend yield?
When is TECH's next dividend payment date?
How much does TECH pay in dividends per year?
Has TECH been increasing its dividend?
Is TECH's dividend safe?
How is TECH's Dividend Safety Rating calculated?
Want to understand how we rate dividend safety? Read our full methodology
Track TECH Dividends with OnlyDividends
What will TECH actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.
This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.
Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.
Market data provided by Twelve Data.